Intro

This chapter delves into the groundbreaking efforts of Big Hat Biosciences in merging synthetic biology with machine learning for antibody drug development. It also emphasizes the significance of personal connections and collaborations in advancing the biotech industry, highlighted by a memorable expedition to Kilimanjaro.